Cell-Mediated Immune Responses in Paraneoplastic Neurological Syndromes
Open Access
- 30 December 2013
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-11
Abstract
Paraneoplastic neurological syndromes (PNS) are disorders of the nervous system that are associated with remote effects of malignancy. PNS are considered to have an autoimmune pathology. It has been suggested that immune antitumor responses are the origin of improved outcome in PNS. We describe cell-mediated immune responses in PNS and their potential contributions to antitumor reactions. Experimental and neuropathological studies have revealed infiltrates in nervous tissue and disturbances in lymphocyte populations in both cerebrospinal fluid and peripheral blood. A predominance of cytotoxic T lymphocytes (CTLs) over T helper cells has been observed. CTLs can be specifically aggressive against antigens shared by tumors and nervous tissue. Based on genetic studies, a common clonal origin of lymphocytes from blood, tumor, and nervous tissue is suggested. Suppressive regulatory T (Treg) lymphocytes are dysfunctional. Simultaneously, in tumor tissue, more intense cell-mediated immune responses are observed, which often coincide with a less aggressive course of neoplastic disease. An increased titer of onconeural antibodies is also related to better prognoses in patients without PNS. The evaluation of onconeural and neuronal surface antibodies was recommended in current guidelines. The link between PNS emergence and antitumor responses may result from more active CTLs and less functional Treg lymphocytes.Keywords
Funding Information
- European Social Fund Plus
This publication has 103 references indexed in Scilit:
- Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognitionJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo-associated paraneoplastic cerebellar degenerationNeuro-Oncology, 2012
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- CDR2 antigen and Yo antibodiesCancer Immunology, Immunotherapy, 2010
- Purkinje Cell Death After Uptake of Anti-Yo Antibodies in Cerebellar Slice CulturesJournal of Neuropathology & Experimental Neurology, 2010
- Screening for tumours in paraneoplastic syndromes: report of an EFNS Task ForceEuropean Journal of Neurology, 2010
- Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodiesJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethalCell, 1991